Full text is available at the source.
BMAL1 Proteostasis, Circadian Dysfunction, and Ferroptotic Vulnerability in Osteoporosis: Current Evidence and Experimental Priorities
Disrupted Daily Protein Control and Cell Death Risk Linked to Bone Loss: Current Findings and Research Needs
AI simplified
Abstract
Current evidence supports that ferroptosis is directly established in osteoblasts and osteocytes across several contexts related to osteoporosis.
- Circadian regulation in bone involves more than just the abundance of BMAL1 and should be understood within a larger biological clock network.
- Ferroptosis, a type of cell death, is implicated in osteoblasts and osteocytes in various osteoporosis-related conditions, including postmenopausal and diabetic scenarios.
- BMAL1 plays a crucial role in the differentiation of skeletal cells and their ability to adapt to stress, although its degradation and related processes in bone cells have not been shown yet.
- Although clockophagy is not an established pathway in skeletal cells, the existing literature provides a framework for exploring the potential pathogenic role of BMAL1 proteostasis in osteoporosis.
AI simplified